The importance of airway and lung microbiome in the critically ill.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
31 08 2020
Historique:
received: 05 05 2020
accepted: 03 08 2020
entrez: 2 9 2020
pubmed: 2 9 2020
medline: 12 9 2020
Statut: epublish

Résumé

During critical illness, there are a multitude of forces such as antibiotic use, mechanical ventilation, diet changes and inflammatory responses that could bring the microbiome out of balance. This so-called dysbiosis of the microbiome seems to be involved in immunological responses and may influence outcomes even in individuals who are not as vulnerable as a critically ill ICU population. It is therefore probable that dysbiosis of the microbiome is a consequence of critical illness and may, subsequently, shape an inadequate response to these circumstances.Bronchoscopic studies have revealed that the carina represents the densest site of bacterial DNA along healthy airways, with a tapering density with further bifurcations. This likely reflects the influence of micro-aspiration as the primary route of microbial immigration in healthy adults. Though bacterial DNA density grows extremely sparse at smaller airways, bacterial signal is still consistently detectable in bronchoalveolar lavage fluid, likely reflecting the fact that lavage via a wedged bronchoscope samples an enormous surface area of small airways and alveoli. The dogma of lung sterility also violated numerous observations that long predated culture-independent microbiology.The body's resident microbial consortia (gut and/or respiratory microbiota) affect normal host inflammatory and immune response mechanisms. Disruptions in these host-pathogen interactions have been associated with infection and altered innate immunity.In this narrative review, we will focus on the rationale and current evidence for a pathogenic role of the lung microbiome in the exacerbation of complications of critical illness, such as acute respiratory distress syndrome and ventilator-associated pneumonia.

Identifiants

pubmed: 32867808
doi: 10.1186/s13054-020-03219-4
pii: 10.1186/s13054-020-03219-4
pmc: PMC7457224
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

537

Subventions

Organisme : Joint Initiative on Antimicrobial Resistance program.
ID : 2018-06335
Pays : International

Références

Methods Enzymol. 2013;531:371-444
pubmed: 24060131
J Hosp Infect. 2019 Jun;102(2):174-188
pubmed: 30926290
Intensive Care Med. 2019 Aug;45(8):1082-1092
pubmed: 31209523
Anal Chem. 2016 Oct 18;88(20):10266-10274
pubmed: 27709906
Nucleic Acids Res. 2016 Jun 2;44(10):e99
pubmed: 26984526
Nat Med. 2018 Oct;24(10):1495-1496
pubmed: 30275567
Cell Microbiol. 2014 Jul;16(7):1024-33
pubmed: 24798552
Thorax. 2017 Sep;72(9):803-810
pubmed: 28100714
Thorax. 2017 Jan;72(1):13-22
pubmed: 27486204
mBio. 2015 Mar 03;6(2):e00037
pubmed: 25736890
Nat Microbiol. 2016 Jul 18;1(10):16113
pubmed: 27670109
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12353-E12362
pubmed: 30482864
BMC Microbiol. 2013 Dec 28;13:303
pubmed: 24373613
Nature. 2012 Sep 13;489(7415):250-6
pubmed: 22972298
Proc Natl Acad Sci U S A. 1977 Oct;74(10):4537-41
pubmed: 16592452
Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F456-62
pubmed: 22562869
Am J Respir Crit Care Med. 2018 Aug 15;198(4):497-508
pubmed: 29533677
BMJ Open. 2019 Jun 20;9(6):e025228
pubmed: 31227528
Annu Rev Genomics Hum Genet. 2012;13:151-70
pubmed: 22703178
Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):37
pubmed: 31346841
Acute Med Surg. 2018 Dec 27;6(2):91-94
pubmed: 30976432
Gut Microbes. 2013 Sep-Oct;4(5):403-8
pubmed: 23941900
Nature. 2010 Mar 4;464(7285):59-65
pubmed: 20203603
Clin Infect Dis. 2015 May 15;60 Suppl 2:S98-107
pubmed: 25922408
J Infect Dis. 1996 Dec;174(6):1279-87
pubmed: 8940219
Lancet. 2014 Aug 23;384(9944):691-702
pubmed: 25152271
mBio. 2015 Jan 20;6(1):
pubmed: 25604788
Microorganisms. 2019 Jan 10;7(1):
pubmed: 30634578
Transl Lung Cancer Res. 2019 Jun;8(3):235-246
pubmed: 31367537
Trends Mol Med. 2020 May;26(5):496-507
pubmed: 32359480
ACS Nano. 2016 Jan 26;10(1):6-37
pubmed: 26695070
Chest. 2017 Feb;151(2):492-499
pubmed: 27771302
Scand J Gastroenterol. 2014 Jun;49(6):681-9
pubmed: 24694282
mBio. 2017 Feb 14;8(1):
pubmed: 28196961
Appl Environ Microbiol. 1998 Aug;64(8):3110-3
pubmed: 9687486
Respir Res. 2019 Nov 6;20(1):246
pubmed: 31694652
J Anat. 1972 Sep;112(Pt 3):391-400
pubmed: 4564685
Front Pharmacol. 2017 Oct 09;8:717
pubmed: 29062279
Crit Care Med. 2017 Feb;45(2):337-347
pubmed: 28098630
Nat Microbiol. 2016 Apr 04;1:16031
pubmed: 27572644
Microbiome. 2015 Jul 30;3:31
pubmed: 26229597
J Antimicrob Chemother. 2014 Aug;69(8):2215-23
pubmed: 24710024
Trends Mol Med. 2015 Jul;21(7):427-32
pubmed: 25907678
Nat Immunol. 2019 Oct;20(10):1279-1290
pubmed: 31501577
N Engl J Med. 2009 Jan 1;360(1):20-31
pubmed: 19118302
Ann Am Thorac Soc. 2015 Jun;12(6):821-30
pubmed: 25803243
J Med Microbiol. 2008 Aug;57(Pt 8):1007-1014
pubmed: 18628503
Yale J Biol Med. 2018 Jun 28;91(2):143-149
pubmed: 29955219
Nat Med. 2017 Jul;23(7):850-858
pubmed: 28530702
JAMA. 2018 Nov 27;320(20):2087-2098
pubmed: 30347072
Nat Biotechnol. 2010 Jun;28(6):595-9
pubmed: 20495550
Cell. 2019 Jan 24;176(3):649-662.e20
pubmed: 30661755
Lancet Infect Dis. 2012 Oct;12(10):774-80
pubmed: 22951600
J Immunol. 2004 Sep 15;173(6):4137-46
pubmed: 15356164
Intensive Care Med. 2017 Jan;43(1):59-68
pubmed: 27837233
Genome Med. 2016 May 10;8(1):52
pubmed: 27159972
Front Nutr. 2018 Oct 02;5:90
pubmed: 30333981
Nat Commun. 2013;4:2689
pubmed: 24162144
Nature. 2013 Dec 19;504(7480):446-50
pubmed: 24226770
Am J Respir Crit Care Med. 2018 Mar 1;197(5):549-551
pubmed: 29091746
Microbiol Rev. 1979 Jun;43(2):260-96
pubmed: 390357
BMC Pulm Med. 2017 Jan 3;17(1):1
pubmed: 28049457
Am J Respir Crit Care Med. 2020 Mar 1;201(5):555-563
pubmed: 31973575
Annu Rev Physiol. 2016;78:481-504
pubmed: 26527186
Nature. 2013 Oct 3;502(7469):96-9
pubmed: 23995682
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
J Crit Care. 2017 Apr;38:84-91
pubmed: 27866110
Intensive Care Med. 2018 Aug;44(8):1203-1211
pubmed: 29936583

Auteurs

Ignacio Martin-Loeches (I)

Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St James Hospital, Dublin 8., Ireland. drmartinloeches@gmail.com.
Department of Respiratory Medicine, Hospital Clinic, IDIBAPS, CIBERes, Barcelona, Spain. drmartinloeches@gmail.com.
Trinity College, Dublin, Ireland. drmartinloeches@gmail.com.

Robert Dickson (R)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, USA.
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, USA.
Michigan Center for Integrative Research in Critical Care, Ann Arbor, MI, USA.

Antoni Torres (A)

Deparment of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB) - SGR 911- Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain.

Håkan Hanberger (H)

Department of Infectious Diseases, Linköping University, Linköping, Sweden.
Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.

Jeffrey Lipman (J)

The University of Queensland, Brisbane, Australia.
Scientific Consultant, Nimes University Hospital, University of Montpellier, Nimes, France.

Massimo Antonelli (M)

Department of Anesthesiology, Intensive Care and Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Università Cattolica del Sacro Cuore, Rome, Italy.

Gennaro de Pascale (G)

Department of Anesthesiology, Intensive Care and Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Università Cattolica del Sacro Cuore, Rome, Italy.

Fernando Bozza (F)

National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.

Jean Louis Vincent (JL)

Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Srinivas Murthy (S)

University of British Columbia, Vancouver, BC, V6H 3V4, Canada.

Michael Bauer (M)

Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.

John Marshall (J)

The Keenan Research Centre for Biomedical Science, The Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

Catia Cilloniz (C)

Deparment of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB) - SGR 911- Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain.

Lieuwe D Bos (LD)

Department of Respiratory Medicine, Infection and Immunity, Amsterdam University Medical Center, AMC, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH